Immunovant, Inc. ( IMVT) - Key Metrics
IMVT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0.03 | -$0.75 | -$0.61 | -$0.61 |
| 2026Q4 | $0 | -$0.73 | -$0.47 | -$0.47 |
| 2026Q3 | $0 | -$0.61 | -$0.51 | -$0.51 |
| 2026Q2 | $0 | -$0.73 | -$0.59 | -$0.59 |
| 2026Q1 | $0 | -$0.71 | -$0.69 | -$0.69 |
IMVT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -12.84 |
| 2026Q4 | 0% | -8.51 |
| 2026Q3 | 0% | -10.42 |
| 2026Q2 | 0% | -5.52 |
| 2026Q1 | 0% | -5.63 |
IMVT
Price: $41.82
52 week price:
Earnings Per Share: -2.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 791496
Market Capitalization: 8.8 billion